Friday, December 12, 2025 | 07:17 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Top headlines: Pfizer's pill cuts risk of severe Covid; Delhi AQI worsens

Business Standard brings you the top headlines on Friday

A man rides a bicycle in front of the historic Red Fort, shrouded in smog post Diwali celebrations in New Delhi (Photo: PTI)
premium

A man rides a bicycle in front of the historic Red Fort, shrouded in smog post Diwali celebrations in New Delhi (Photo: PTI)

BS Web Team New Delhi
Pfizer develops Covid pill that cuts hospitalisations and deaths by 89%

Pfizer Inc. said its Covid-19 pill reduced hospitalisations and deaths in high-risk patients by 89%, a result that has the potential to upend how the disease caused by the coronavirus is treated and alter the course of the pandemic.

The drugmaker said in a statement on Friday that it was no longer taking new patients in a clinical trial of the treatment “due to the overwhelming efficacy” and planned to submit the findings to U.S. regulatory authorities for emergency authorization as soon as possible. Read more